Novartis International AG

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH

---

Novartis International AG Company Summary

Novartis offers a wide range of healthcare products through our Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health Divisions.

COMPANY DATA

	Principal Sector	Health & Pharm
	Principal Industry	Pharmaceutical
	Homepage	www.novartis.com

---

Key Developments: Novartis International AG

	CFO Summit Europe 2011 To Focus On Compliance, Governance And The Impact of Regulatory Change MAY 17, 2011 17:49 - Article Views: 985 Compliance, governance and the impact of regulatory change are just some of the issues that will no doubt be on the agenda at the CFO Summit Europe 2011, which takes place from 13-15 September at The Oitavos, Cascais in Portugal. This closed-door summit, hosted by GDS International, features some of the leading voices in the European CFO sector, including Ramon Zapata, Head of Finance Operations at Novartis (NYSE:NVS); Olivier Klaric, VP Treasury at Sanofi Aventis Group (NYSE:SNY); Erik Ter Horst, CFO EMEA and VP of Finance for BT (NYSE:BT); and Clive Parrit, Vice President of the Institute of Chartered Accountants.
	Novartis International AG (VTX:NOVN) Rasilez®, First-in-class Direct Renin Inhibitor, Provides Greater Reduction In High Blood Pressure Than ACE Inhibitor Ramipril In Patients 65 And Older NOV 12, 2008 02:33 - Article Views: 2,084 Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) Rasilez HCT®, Single-pill Combination Of Rasilez® And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure OCT 29, 2008 17:19 - Article Views: 1,903 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) ACZ885 Phase III Data Show Rapid, Sustained Clinical Remission In Children And Adults Suffering From A Group Of Rare, Potentially Life-threatening Autoinflammatory Diseases OCT 27, 2008 17:17 - Article Views: 2,032 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) Novartis To Acquire Nektar Therapeutics Pulmonary Business Unit, Strengthening Respiratory Drug Delivery Capabilities OCT 21, 2008 16:17 - Article Views: 835 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) Novartis Delivers Sustained Strong Performance In First Nine Months Of 2008 Underpinned By Accelerating Growth In Pharmaceuticals OCT 20, 2008 15:03 - Article Views: 2,244 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) Early Data Show Potential For Imatinib To Treat Life-threatening Form Of Pulmonary Artery Disease OCT 8, 2008 15:17 - Article Views: 2,406 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) New Phase II Data On NVA237, A Novel Once-daily Treatment For COPD, show Promising Efficacy And Tolerability With Potentially Faster Onset Than Tiotropium OCT 7, 2008 15:17 - Article Views: 1,177 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) New Study Shows Potential Benefits Of Innovative Xolair® Anti-ige Therapy In Treating Children Suffering From Moderate-to-severe Allergic Asthma OCT 6, 2008 15:17 - Article Views: 437 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
	Novartis International AG (SWF:NOVN) Once-yearly Aclasta® Approved In EU To Treat Osteoporosis In Men And To Reduce Risk Of New Fractures Following Hip Fracture Both In Men And Postmenopausal Women SEP 30, 2008 15:17 - Article Views: 1,402 Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

4,519 COMPANY PROFILE VIEWS

This Page Viewed: (Last 7 Days: 22) (Last 30 Days: 112) (Since Published: 1902)